comparemela.com

Page 2 - India Based Bharat Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Despite an 80% Drop, Ocugen Stock Is Still Too Pricey

Until the hype surrounding its Covid-19 vaccine candidate is no longer priced into shares, it's best to avoid OCGN stock.

COVID-19 vaccine sprayed in the nostrils could replace shots in arms

vimarsana © 2020. All Rights Reserved.